Cover Image

Guidance for industry : submission of summary bioequivalence data for ANDAs.

Bibliographic Details
Corporate Author:	Center for Drug Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Subjects:	Drugs > United States > Therapeutic equivalency. Drugs > Certification > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112216

Similar Items

Guidance for industry : statistical approaches to establishing bioequivalence.
Published: (2001)

Guidance for industry : food-effect bioavailability and fed bioequivalence studies.
Published: (2002)

Guidance for industry : bioequivalence recommendations for specific products.
Published: (2007)

Guidance : topical dermatologic corticosteroids, in vivo bioequivalence.
Published: (1995)

Guidance for industry : clozapine tables, in vivo bioequivalence and in vitro dissolution testing.
Published: (2005)

Generic drug product development : bioequivalence issues /
Published: (2008)

Guidance for industry : nonsterile semisolid dosage forms : scale-up and postapproval changes : chemistry, manufacturing, and controls : in vitro release testing and in vivo bioequivalence documentation.
Published: (1997)

Bioequivalence studies in drug development : methods and applications /
by: Hauschke, Dieter
Published: (2007)

Bioequivalence and statistics in clinical pharmacology /
by: Patterson, Scott D.
Published: (2006)

Generics and bioequivalence /
Published: (1994)

Guidance for indusry : bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action.
Published: (2003)

Guidance for industry : waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system.
Published: (2000)

Guidance for industry : SUPAC-MR : modified release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation.
Published: (1997)

Guidance for industry : immediate release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation.
Published: (1995)

Design and analysis of bioavailability and bioequivalence studies /
by: Chow, Shein-Chung, 1955-
Published: (2009)

Guidance for industry : handling and retention of BA and BE testing samples.
Published: (2004)

Pharmaceutical bioequivalence /
Published: (1991)

Mosby's drugconsult.
Published: (2002)

Design and analysis of bioavailability and bioequivalence studies /
by: Chow, Shein-Chung, 1955-
Published: (2000)

Guidance for industry : potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing.
Published: (2005)

Bioequivalence studies in drug development : methods and applications /
by: Hauschke, Dieter
Published: (2007)

Resistant prices : a study of competitive strains in the antibiotic markets /
by: Brooke, Paul A.
Published: (1975)

Pharmacology and the healthcare professional.
Published: (2011)

Drug reference guide to brand names and active ingredients /
by: Pagliaro, Louis A.
Published: (1986)

Expanding the use of generic drugs.
Published: (2010)

Approved drug products with therapeutic equivalence evaluations.
Published: (1985)

Approved drug products with therapeutic equivalence evaluations.

If you didn't finish high school but still want a diploma-- /
Published: (1979)

Orange book : approved drug products with therapeutic equivalence evaluations.

Brands, generics, prices and quality; the prescribing debate after a decade.
Published: (1971)

Topical drug bioavailability, bioequivalence, and penetration /
Published: (1993)

Guidance for industry : ANDAs, impurities in drug substances.
Published: (2009)

Guidance for industry : ANDAs, impurities in drug products.
Published: (2005)

Guidance for industry : changes to an approved NDA or ANDA.
Published: (2004)

Guidance for industry : revising and ANDA labeling following revision of the RLD labeling.
Published: (2000)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Guidance for industry : changes to an approved NDA or ANDA, questions and answers.
Published: (2001)

Drug-poisoning deaths involving heroin : United States, 2000-2013 /
by: Hedegaard, Holly, et al.
Published: (2015)

Guidance for industry : variations in drug products that may be included in a single ANDA.
Published: (1998)

Guidance for industry : accelerated approval products, submission of promotional materials.
Published: (1999)